1. Home
  2. EYPT vs SENEA Comparison

EYPT vs SENEA Comparison

Compare EYPT & SENEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SENEA
  • Stock Information
  • Founded
  • EYPT 1987
  • SENEA 1949
  • Country
  • EYPT United States
  • SENEA United States
  • Employees
  • EYPT N/A
  • SENEA N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SENEA Packaged Foods
  • Sector
  • EYPT Industrials
  • SENEA Consumer Staples
  • Exchange
  • EYPT Nasdaq
  • SENEA Nasdaq
  • Market Cap
  • EYPT 741.0M
  • SENEA 710.1M
  • IPO Year
  • EYPT 2005
  • SENEA N/A
  • Fundamental
  • Price
  • EYPT $14.00
  • SENEA $113.97
  • Analyst Decision
  • EYPT Strong Buy
  • SENEA
  • Analyst Count
  • EYPT 6
  • SENEA 0
  • Target Price
  • EYPT $25.83
  • SENEA N/A
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • SENEA 44.8K
  • Earning Date
  • EYPT 11-06-2025
  • SENEA 11-05-2025
  • Dividend Yield
  • EYPT N/A
  • SENEA N/A
  • EPS Growth
  • EYPT N/A
  • SENEA N/A
  • EPS
  • EYPT N/A
  • SENEA 6.24
  • Revenue
  • EYPT $51,898,000.00
  • SENEA $1,571,618,000.00
  • Revenue This Year
  • EYPT N/A
  • SENEA N/A
  • Revenue Next Year
  • EYPT N/A
  • SENEA N/A
  • P/E Ratio
  • EYPT N/A
  • SENEA $18.02
  • Revenue Growth
  • EYPT 2.99
  • SENEA 7.30
  • 52 Week Low
  • EYPT $3.91
  • SENEA $60.92
  • 52 Week High
  • EYPT $14.91
  • SENEA $115.40
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 58.99
  • SENEA 64.91
  • Support Level
  • EYPT $13.00
  • SENEA $110.49
  • Resistance Level
  • EYPT $14.04
  • SENEA $113.40
  • Average True Range (ATR)
  • EYPT 0.93
  • SENEA 2.58
  • MACD
  • EYPT -0.08
  • SENEA 0.72
  • Stochastic Oscillator
  • EYPT 62.87
  • SENEA 96.71

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SENEA Seneca Foods Corp.

Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.

Share on Social Networks: